Literature DB >> 8705227

A retrospective analysis of 82 cases of cancer of the penis.

J C Lindegaard1, O S Nielsen, F A Lundbeck, A Mamsen, H N Studstrup, H von der Maase.   

Abstract

OBJECTIVE: To identify prognostic factors for penile cancer and to evaluate the treatment strategy for early-stage disease, proposed recently by the European Board of Urology (EBU). PATIENT AND METHODS: The records of 82 patients consecutively referred to the uro-oncological centre at Aarhus University Hospital between 1965 and 1993 were reviewed. The importance of tumour stage, differentiation, patient age, local control and regional lymph node control were assessed using univariate and multivariate analyses.
RESULTS: Cox multivariate analysis identified differentiation (odds ratio [OR] = 6.04), UJCC-1978 T-stage (OR = 1.88) and age (OR = 1.04) as independent prognostic variables for survival. Penile amputation in tumours < 4 cm in diameter improved local control but not survival. Regional control and survival were not significantly improved by prophylactic adenectomy.
CONCLUSION: Differentiation, T-stage and age were prognostic factors for survival. The results support the EBU treatment strategy involving penis-conserving therapy and watchful waiting for early-stage disease.

Entities:  

Mesh:

Year:  1996        PMID: 8705227     DOI: 10.1046/j.1464-410x.1996.02221.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Penile cancer: a case for guidelines.

Authors:  N P Munro; P J Thomas; G P Deutsch; N J Hodson
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

Review 2.  Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience.

Authors:  Paul K Hegarty; Majid Shabbir; Ben Hughes; Suks Minhas; Matthew Perry; Nicholas Watkin; David J Ralph
Journal:  World J Urol       Date:  2008-07-18       Impact factor: 4.226

Review 3.  The role of penectomy in penile cancer-evolving paradigms.

Authors:  Sarah O'Neill; Mitchell Barns; Filip Vujovic; Mikhail Lozinskiy
Journal:  Transl Androl Urol       Date:  2020-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.